Core Viewpoint - The article highlights the successful completion of nearly 100 million RMB in Series B financing for Jinghai Weixiang Biotech Co., Ltd., which will enhance the company's technological advancements, production capacity, and market expansion in the biobased materials sector [1][3]. Group 1: Financing and Growth - The Series B financing was exclusively invested by Jiazhih Fund, with Kaicheng Capital serving as the advisor and continuing to assist in subsequent fundraising efforts [1]. - The funds will primarily be used for expanding the production capacity of the company's scale-up production base, iterative research and development of next-generation technologies, and market channel expansion [3]. - The company has achieved significant milestones in the industrialization of biobased materials, with steady increases in production capacity and market share, and this financing will further accelerate its growth process and solidify its industry-leading position [3]. Group 2: Technological Advancements - Jinghai Weixiang has developed several internationally leading production technologies for the entire biobased materials industry chain, focusing on key breakthroughs such as "non-grain biomass utilization," "next-generation industrial strains," "gypsum-free lactic acid technology," and "rPLA recycling" [2]. - The "gypsum-free lactic acid technology" addresses the environmental pollution caused by gypsum waste in traditional lactic acid production, enabling cleaner and lower-cost production [2]. - The "rPLA recycling" process not only allows for the recycling of polylactic acid (PLA) but also effectively reduces production costs, contributing to a sustainable development cycle for biobased materials [2]. Group 3: Product and Market Applications - The core product, polylactic acid (PLA), is a high-performance biodegradable material with excellent biocompatibility, degradability, and processing capabilities, widely used in various sectors including fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [2]. - With its comprehensive industry chain layout, Jinghai Weixiang can control the entire process from raw material supply to biobased material production and recycling, ensuring product quality stability and providing significant cost advantages and market competitiveness [2].
聚焦“AI+合成生物+生物基材料”,这一公司获近亿元B轮融资!
synbio新材料·2026-01-12 08:11